Universitätsklinikum Köln
- Address
- Kerpener Straße 62, 50937 Cologne, Germany
High‑Risk Neuroblastoma Trials
Research at Universitätsklinikum Köln focuses on high‑risk neuroblastoma, an aggressive childhood cancer within the neoplasm therapeutic area. The studies aim to improve long‑term survival by comparing intensive chemotherapy approaches and adding targeted immunotherapy.
- Comparison of single versus tandem high‑dose chemotherapy regimens
- Integration of chemoimmunotherapy with dinutuximab beta for inadequate responders
- Evaluation of radiotherapy dose escalation after high‑dose treatment
- Measurement of three‑year event‑free survival outcomes
The department collaborates with international groups such as SIOP‑Europe to refine therapeutic strategies for children facing this disease.
Stage IV Childhood Renal Tumour Studies
In the pediatric oncology unit, investigators assess treatment options for stage IV childhood renal tumour with metastatic spread. The primary goal is to determine whether a six‑week pre‑operative regimen of VCE is not inferior to the traditional VAD protocol, focusing on overall metastatic response, including pulmonary and non‑pulmonary sites.
- Non‑inferiority assessment of pre‑operative chemotherapy regimens
- Analysis of metastatic rapid response rates
- Specific evaluation of pulmonary response outcomes
- Outcomes for non‑pulmonary metastatic lesions
Conducted by the pediatric oncology department at Universitätsklinikum Köln, these trials seek to optimize first‑line therapy for children with advanced renal cancers.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1GPOH gGmbH1active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Universitätsklinikum Köln
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Phase 3 Non-Inferiority Trial of Vincristine, Actinomycin-D, and Doxorubicin Versus Vincristine, Carboplatin, and Etoposide in Stage IV Pediatric Renal Tumors | GPOH gGmbH | Phase III | Recruiting | Dec 2019 | — |
IMP list
lock Showing 1 of 15 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Carboplatin | 2 | Unknown | 2019-12-05 | 2024-11-21 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.